Yan Ming 4

What Happened

• Yan Ming, Chief Technology Officer and a director at Cytek Biosciences (CTKB), reported a disposition by gift of 1,176,000 shares on 2026-03-13. The reported transaction price is $0.00, so there were no sale proceeds—this was a gift (SEC code G), not an open-market sale.

Key Details

• Transaction date: 2026-03-13
• Transaction type/code: Gift (G); disposition of 1,176,000 shares
• Reported price/value: $0.00 per share; total proceeds reported as $0
• Filing date: 2026-03-13 (filed same day as the transaction)
• Shares owned after transaction: Not specified in the information provided
• Notable footnotes: None reported in the provided excerpt (no 10b5-1 plan or tax-withholding note disclosed)

Context

• Gifts are reported as dispositions but do not necessarily signal the insider’s view of the company’s prospects; they often reflect personal, estate-planning, or family transfers. For retail investors, purchases typically carry more direct informational weight than gifts or routine dispositions.